Royalty Pharma plc
RPRX
Peringkat dalam Saham
#894
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$60.39
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$26.89B
Perubahan (1 hari)
-0.93%
Perubahan (1 tahun)
64.87%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Riwayat dividen untuk Royalty Pharma plc (RPRX)
Saham Royalty Pharma plc (simbol: RPRX) telah membayar total 23 dividen.
Total semua dividen (disesuaikan dengan stock split): $4.50
Imbal hasil dividen (TTM): 0.0157
Total semua dividen (disesuaikan dengan stock split): $4.50
Imbal hasil dividen (TTM): 0.0157
Pembayaran dividen untuk Royalty Pharma plc (RPRX) dari 2020 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (disesuaikan dengan stock split) | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Daftar semua pembayaran dividen
| Tahun | Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Pembayaran dividen untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
|
| 69.00% |
HK
|
